Pathfinder Cell Therapy Stock Market Value
| PFND Stock | USD 0.0001 0.00 0.00% |
| Symbol | Pathfinder |
Pathfinder Cell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pathfinder Cell's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pathfinder Cell.
| 12/14/2022 |
| 12/03/2024 |
If you would invest 0.00 in Pathfinder Cell on December 14, 2022 and sell it all today you would earn a total of 0.00 from holding Pathfinder Cell Therapy or generate 0.0% return on investment in Pathfinder Cell over 720 days. Pathfinder Cell is related to or competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, Anebulo Pharmaceuticals, Rezolute, and HCW Biologics. Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-deriv... More
Pathfinder Cell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pathfinder Cell's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pathfinder Cell Therapy upside and downside potential and time the market with a certain degree of confidence.
Pathfinder Cell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pathfinder Cell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pathfinder Cell's standard deviation. In reality, there are many statistical measures that can use Pathfinder Cell historical prices to predict the future Pathfinder Cell's volatility.Pathfinder Cell Therapy Backtested Returns
We have found three technical indicators for Pathfinder Cell Therapy, which you can use to evaluate the volatility of the company. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Pathfinder Cell are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Pathfinder Cell Therapy has no correlation between past and present. Overlapping area represents the amount of predictability between Pathfinder Cell time series from 14th of December 2022 to 9th of December 2023 and 9th of December 2023 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pathfinder Cell Therapy price movement. The serial correlation of 0.0 indicates that just 0.0% of current Pathfinder Cell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Pathfinder Cell Therapy lagged returns against current returns
Autocorrelation, which is Pathfinder Cell pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pathfinder Cell's pink sheet expected returns. We can calculate the autocorrelation of Pathfinder Cell returns to help us make a trade decision. For example, suppose you find that Pathfinder Cell has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pathfinder Cell regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pathfinder Cell pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pathfinder Cell pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pathfinder Cell pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Pathfinder Cell Lagged Returns
When evaluating Pathfinder Cell's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pathfinder Cell pink sheet have on its future price. Pathfinder Cell autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pathfinder Cell autocorrelation shows the relationship between Pathfinder Cell pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Pathfinder Cell Therapy.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pathfinder Pink Sheet
Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.